Furthermore, by improving the organ index and pathological damage of the liver and kidneys, as well as TG, TC, INS, GSP, and FBG levels in serum, SOD, CAT, GSH enzyme activities, and MDA content in the liver of T2DM rats, PSP exhibited its therapeutic effect on T2DM rats. The gene discussed is GNAS; the disease is type 2 diabetes mellitus.